{
     "PMID": "11897157",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20020523",
     "LR": "20131121",
     "IS": "0304-3940 (Print) 0304-3940 (Linking)",
     "VI": "322",
     "IP": "3",
     "DP": "2002 Apr 12",
     "TI": "Nicotinamide and ketamine reduce infarct volume and DNA fragmentation in rats after brain ischemia and reperfusion.",
     "PG": "137-40",
     "AB": "The possible ability of nicotinamide and ketamine to decrease infarction volume and DNA fragmentation was investigated in a middle cerebral artery occlusion rat model. DNA fragmentation was measured with an enzyme linked immunoassay. Control infarct volume was 223.8 +/- 10.6 mm(3). Ketamine alone did not alter infarct volume, 233.2 +/- 61.8 mm(3). Nicotinamide alone did not alter infarct volume, 235.2 +/- 62.8 mm(3). The combination of ketamine and nicotinamide decreased infarct volume to 83.8 +/- 35.2 mm(3). Ketamine produced hypothermia. Nicotinamide and ketamine decreased brain swelling and DNA fragmentation in the cerebral cortex, striatum and hippocampus in rats perfused for 6 or 24 h. Ketamine may synergize the actions of nicotinamide and partially prevent brain damage from ischemia and reperfusion.",
     "FAU": [
          "Chang, Mei Ling",
          "Yang, Jun",
          "Kem, Seyha",
          "Klaidman, Lori",
          "Sugawara, Taku",
          "Chan, Pak H",
          "Adams, James D Jr"
     ],
     "AU": [
          "Chang ML",
          "Yang J",
          "Kem S",
          "Klaidman L",
          "Sugawara T",
          "Chan PH",
          "Adams JD Jr"
     ],
     "AD": "Department of Molecular Pharmacology and Toxicology, University of Southern California, School of Pharmacy, 1985 Zonal Avenue, PSC 508, Los Angeles, CA 90089-9121, USA.",
     "LA": [
          "eng"
     ],
     "GR": [
          "NS14543/NS/NINDS NIH HHS/United States",
          "NS25372/NS/NINDS NIH HHS/United States",
          "NS36147/NS/NINDS NIH HHS/United States",
          "NS38653/NS/NINDS NIH HHS/United States"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't",
          "Research Support, U.S. Gov't, P.H.S."
     ],
     "PL": "Ireland",
     "TA": "Neurosci Lett",
     "JT": "Neuroscience letters",
     "JID": "7600130",
     "RN": [
          "0 (Excitatory Amino Acid Antagonists)",
          "0 (Nicotinic Agonists)",
          "25X51I8RD4 (Niacinamide)",
          "690G0D6V8H (Ketamine)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Brain Ischemia/*pathology",
          "Cerebral Infarction/*drug therapy/*pathology",
          "DNA Fragmentation/*drug effects",
          "Excitatory Amino Acid Antagonists/*pharmacology",
          "Ketamine/*pharmacology",
          "Male",
          "Middle Cerebral Artery",
          "Niacinamide/*pharmacology",
          "Nicotinic Agonists/*pharmacology",
          "Rats",
          "Rats, Wistar",
          "Reperfusion Injury/*pathology"
     ],
     "EDAT": "2002/03/19 10:00",
     "MHDA": "2002/05/25 10:01",
     "CRDT": [
          "2002/03/19 10:00"
     ],
     "PHST": [
          "2002/03/19 10:00 [pubmed]",
          "2002/05/25 10:01 [medline]",
          "2002/03/19 10:00 [entrez]"
     ],
     "AID": [
          "S0304394001025204 [pii]"
     ],
     "PST": "ppublish",
     "SO": "Neurosci Lett. 2002 Apr 12;322(3):137-40.",
     "term": "hippocampus"
}